Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER_GOV
×
Irinotecan
×
Clear all
Filters
3
NCT04776655
2025-10-02
LIBImAb
Azienda USL Reggio Emilia - IRCCS
Phase 3
Recruiting
280 enrolled
NCT01501669
2012-07-18
PROCEED
National Cancer Center, Korea
Phase 3
Unknown
222 enrolled